Study author Dr Emmanuel During, an associate professor of neurology and medicine at Mount Sinai School of Medicine in New York, said: “This automated approach could be integrated into clinical ...
an early manifestation of synucleinopathy that affects 1% to 1.5% of the middle-aged and older populations,” Emmanuel During, MD, associate professor of neurology at Icahn School of Medicine at ...